PredictrPK UST

About Prometheus Labs

Prometheus Laboratories is a commercial-stage, private diagnostics company with a deep focus on GI diseases, particularly Inflammatory Bowel Disease (IBD). It has built an industry-leading portfolio of proprietary tests that provide actionable data across the entire patient care continuum, performing over one million tests annually. The company leverages its scientific expertise in immunology and drug metabolism to offer precision-guided solutions for therapy selection, dosing optimization (PredictrPK), and therapeutic drug monitoring (Anser series). Its recent launch of IBD Precis™ and expansion of its dosing tests demonstrate a commitment to innovation within its core market.

Therapeutic Areas